Kiniksa Pharmaceuticals International, plc
$79.28
+0.65 (+0.83%)
Price as of Sep 01, 2026 market close
Performance
- 1 Month
- +8.0%
- 3 Months
- +69.0%
- YTD
- +92.2%
- 1 Year
- +136.7%
Price return, based on split- and dividend-adjusted closing prices.
Risk
- Volatility 1-year annualized
- 49.7%
- Largest decline max drawdown, since Aug 2025
- -21.1%
- Risk-adjusted return Sharpe ratio, 1-year
- 1.97
Own KNSA?
See how KNSA contributes to your portfolio's return, allocation, and risk.
7-day free trial, then $9/month.